REG - AIM - AIM Notice - 15/12/2025

Concurrent TechnologiesAnnouncement

Today 09:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251215:nRSO4466La&default-theme=true

RNS Number : 4466L  AIM  15 December 2025

NOTICE

 

15/12/2025 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 Challenger Energy Group PLC
 20,043,463  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BPLZ1D8)(IM00BPLZ1D89)

 

 Concurrent Technologies Plc
 100,000  ORDINARY SHARES OF 1P EACH, FULLY PAID  (0218319)(GB0002183191)

 

 CRISM Therapeutics Corporation
 11,111,112  ORDINARY SHARES OF NO PAR VALUE, FULLY PAID  (BS60QF6)(VGG042401262)

 

 MicroSalt plc
 3,839,090  ORDINARY SHARES OF £0.001625 EACH   (BQB6FF8)(GB00BQB6FF85)

 

 Netcall Plc
 3,378,664  ORDINARY SHARES OF 5P EACH, FULLY PAID  (0006053)(GB0000060532)

 

 Shearwater Group Plc                                  Block Admission
 475,000      ORDINARY SHARES OF 10P EACH, FULLY PAID  (BKT6VH2)(GB00BKT6VH21)

 

 Tap Global Group PLC
 1,200,000  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (BMVSDN0)(GB00BMVSDN09)

 

 Zinc Media Group Plc
 441,273  ORDINARY SHARES OF 0.125P EACH, FULLY PAID  (BJVLR25)(GB00BJVLR251)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUBDDLDBDGUD



            Copyright 2019 Regulatory News Service, all rights reserved